baber/WOPTO huggingface dataset:
Patent JP-2000506575-A (JP)
Title: 掘削孔内でドリルストリング構成部品を案内する着脱式案内部材
IPC: E21B17/10
Filed: 1997-03-14
Abstract: (57)【要約】
ドリルストリング構成部品を掘削孔の中で案内する着脱式案内部材が中心軸線を備え、穴がその軸線に沿って伸びている細長い本体を備えている。この本体は、中心軸線に対して予め選択した半径方向寸法を備えるヘッド端で終わっている。案内部材は、隣接するドリルストリング構成部品にねじ結合されるように構成されている。ヘッド端半径方向寸法は、掘削孔側壁にごく近接してその外面との間に一定距離をおくように予め選択されて、ドリルストリングが一線整列からそれ始める場合、ヘッドエンドの外面は、掘削孔側壁に接触して一線整列を安定にする。案内部材をドリルストリングに沿って任意の位置に挿入できる。
Patent JP-2001512629-A (JP)
Title: パワー半導体デバイス
IPC: H01L29/78
Filed: 1998-12-14
Abstract: (57)【要約】
本発明のパワー半導体デバイスはマルチセル形絶縁ゲート電界効果トランジスタ構造を具え、各セル(100)はメッシュ状ゲート電極(11)の対応する開口部(110)に存在する。各セル(100)及び開口部(110)は縦長側縁（Ｘ）を有する細長形状であり、その縦長側縁に沿ってゲート電極(11)の縦長部分(11x)の下部のゲート絶縁層(12)の下にチャネル領域(1)が存在する。チャネル領域(1)は細長セル(100)の端部（Ｚ）には存在しない。ゲート電極(11)の縦長部分（11x）をゲート絶縁層(12)より厚い厚膜絶縁層(13)上に位置するゲート電極(11)の相互接続部分(11z)によって細長セル(100)の端部を超えて相互接続するのが好ましい。この厚膜絶縁層(13)は隣接する細長セル(100)の互いに対向する、チャネル領域が存在しない端部（Ｚ）の間に存在する。
Patent JP-2000509485-A (JP)
Title: 対象物の位置検出方法
IPC: G01S17/87
Filed: 1997-02-06
Abstract: (57)【要約】
光学的送信器および光学的受信器を有する測定装置に対する対象物の位置を検出する方法および装置であって、前記送信器は光ビームを変化する送信角の下で照射し、前記受信器は前記送信器から間隔をおいて配置されており、かつ角度分解能を有し、それぞれの送信角および受信器が対象物から反射されたビームを受信する角度（受信角）から、送信器および受信器の角度分解能により定められた分解セルのどれに対象物が存在するかが推定され、送信器から照射される光ビームは変調される。送信された光ビームの変調と受信されたビームの変調との位相差が測定される。この位相差からそれぞれの分解セルにおける対象物の位置が計算される。
Patent JP-H11506086-A (JP)
Title: ウェブ巻取装置
IPC: B65H18/04
Filed: 1996-05-22
Abstract: (57)【要約】
ウェブ巻取装置（90）と操作する方法は開示されている。装置には、旋回アセンブリ（200）、巻芯装填装置（1000）と巻芯取外し装置（2000）備えることができる。旋回アセンブリ（200）は、上のウェブ（50）が巻取られる中空の巻芯（302）を噛み込むために回転できるように駆動される心棒（300）を支持する。各心棒（300）は非円形の心棒専用通路（320）の中で駆動される。巻芯搭載装置（1000）は、心棒（300）の運動中に、心棒専用通路（320）の巻芯装填分節（322）に沿って、巻芯（302）を心棒（300）に搬送し、巻芯取外し装置（2000）は、心棒専用通路（320）の巻芯取外し分節（326）に沿った心棒（200）の運動中に各ウェブが巻取られた心棒（302/51）を関連する心棒（300）から取り外す。旋回アセンブリ（200）を、連続的に回転させることができ、また旋回アセンブリ（200）が回転するとき、各巻き上げ棒（51）のシートの枚数を変更することができる。装置（90）には、変形可能な巻芯噛み込み部材（3100）を有する心棒（300）を備えることができる。
Patent JP-2001514561-A (JP)
Title: ポリアミドとアイオノマーとのブレンドを含むゴルフボール
IPC: A63B37/00
Filed: 1998-03-09
Abstract: (57)【要約】
本発明は、カバー層、コア層及び中間層を含むゴルフボールに関する。該層の少なくとも１種は、ポリアミドとアイオノマーとのブレンドである。本発明は、また、カバー及びコアを含むゴルフボールであって、該カバーがポリアミドとアイオノマーとのブレンドである、前記ゴルフボールに関する。
Patent JP-2001517220-A (JP)
Title: 新規カルボン酸誘導体、その製造法、およびこれを癌の治療に使用する方法
IPC: A61K31/53
Filed: 1998-03-09
Abstract: (57)【要約】
エンドセリンの調節が行われる腫瘍としての癌（例えば、前立腺、肺、肝臓、胸、脳、胃、結腸、子宮内膜、睾丸、甲状腺、脳下垂体、膀胱、腎臓、膵臓および髄膜）の腫瘍）を治療するために、本明細書に記載の式（Ｉ）または式（Ｉａ）の化合物を有効量で個体に投与し、癌を治療する方法が提供される。
Patent JP-2001524180-A (JP)
Title: 改良された燃料ポート制御を有する２サイクル内燃機関
IPC: F02B25/14
Filed: 1998-04-27
Abstract: (57)【要約】
ポート制御式の２サイクルエンジン（１）は、燃焼チャンバ（８）と、燃料混合気を含むクランクケース（２）と、シリンダ（５）と、シリンダ（５）内で作動するピストン（１５）と、シリンダの壁の吸気ポート（１８）で終わる、燃料混合気をエンジン（１）まで運ぶ吸気口（１７）と、回転軸を中心にして回転するようにクランクケース（２）内に取り付けられた少なくとも１つのフライホイールとを備えている。フライホイールの回転は、フライホイールの外周直近にある燃料混合気の境界層を外周に沿って駆動するように作動する。エンジン(１)はさらに、シリンダの壁にクランクケース(２)に隣接して存在する第１の移送ポート（２２）からシリンダの壁に燃焼チャンバ（８）に隣接して存在する第２の移送ポート(２３)まで伸長する、燃料混合気をクランクケース(２)から燃焼チャンバ（８）へ運ぶ移送通路（２１）を備え、第１の移送ポート（２２）は実質上回転の軸に対して半径方向に位置している。
Patent JP-2001526568-A (JP)
Title: 人工人体流体
IPC: A61K35/14
Filed: 1998-05-09
Abstract: (57)【要約】
約10から約60重量パーセントの血球と、約20から50重量パーセントの卵白及び血漿とから作られた人体流体類似物を提供する。
Patent JP-2001525727-A (JP)
Title: 渦流チャンバでの物質の制御された粉砕
IPC: B02C19/00
Filed: 1998-05-22
Abstract: (57)【要約】
本発明は、粒子状固形物質を所定寸法の粒子へと粉砕する制御粉砕方法を記述しており、また、粒子の渦流チャンバ(Ｂ、Ｃ、Ｄ、Ｅ、Ｆ、Ｈ、Ｇ、Ｉ)を記述しており、この渦流粉砕チャンバは、２つの端面(３および４)およびチャンバへの作動流体の注入用の少なくとも１つのノズル(７)付きの円筒形側壁(５)、粒子状固形物質を渦流チャンバへと導入するための手段(８)、作動流体流中の粉砕物質をチャンバから排出するための中心軸方向通路(９)、および渦流チャンバでの粉砕工程を制御するための１つまたはそれ以上の機械的要素(13、15、17、19、24、28、29)を有する。この方法は、渦流チャンバに作動流体を接線方向で注入すること、渦流チャンバにて渦流を作り出すために、粒子状固形物質を導入すること(この場合、この粒子状物質は、作動流体の流れにおいて、粉砕を受ける)、および機械的要素(これは、渦流チャンバに設けられ、そしてこのような粒子と相互作用するように適合されている)によって、渦流内で渦流チャンバの内壁に近づいて移動している粒子のチャンバからの排出を慎重に加速または遅延することにより、その中の粒子の粉砕均一性および寸法を制御することを包含する。
Patent MD-20010133-A (MD)
Title: Wind plant (variants)
Inventor: BURCIU VITALIE
IPC: F03D3/00
Filed: 2001-05-14
Abstract: The invention relates to windmills, in particular to the wind plants for the conversion of wind power into electric power.The result of the invention consists in increasing the capacity of the plant.
Patent MD-20080261-A (MD)
Title: Steam engine
Inventor: MIHAILOV GHEORGHE
IPC: F01K3/10
Filed: 2008-10-15
Abstract: The invention relates to the mechanical engineering, namely to the steam engines.The steam engine comprises two cylinders, inside which displaces a piston, each being joined by means of a connecting rod with a crankshaft. The crankshafts are joined between them by a reduction gear providing a reduction ratio of 1:2. The cylinder, which piston displaces twice faster, comprises admission and vent holes and an injector. The cylinder, which piston displaces twice slower, comprises a valve which opens at the discharge of the mix consisting of discharge gases and steam.Fig. 1
Patent NZ-244436-A (NZ)
Title: Vasoocclusive coil and pusher therefor with interlocking/detachable protuberances
Inventor: TWYFORD ROBERT H
IPC: A61B17/12
Filed: 1992-09-22
Abstract: A detachable pusher-vasoocclusive coil assembly (11) for use in occluding a selected site within a vessel, comprising in combination:       a vasoocclusive coil (13) having a proximal end; and   a pusher (12) having a distal end;     characterised in that: a first radial protuberance (16) is carried on the proximal end of the coil solely by means of a proximally extending wire (15); a second radial protuberance (20) is carried on the distal end of the pusher (12) solely by means of a distally extending wire (19); said radial protuberances (16,20) are adapted to be engaged by being axially overlapped and interlocked, with the first protuberance (16) positioned proximally of the second protuberance (20), with the proximally extending wire (15) extending axially past the second protuberance (20) and with the distally extending wire (19) extending axially past the first protuberance (16); and the assembly further comprises means (14,21) carried coaxially about the pusher (12) and coil (13) that is axially movable relative to the coil and pusher from a first position, in which the means radially encloses the engaged protuberances (16,20) to prevent them from substantial radial movement relative to each other to prevent their disengagement, to a second position in which the means does not radially enclose the protuberances and the protuberances are free to disengage.   <IMAGE>
Patent NZ-250873-A (NZ)
Title: Teat with stiffening web transverse to and integral with reinforcing on either side of slit
Inventor: MCINNES ROSS GORDON
IPC: A61J11/00
Filed: 1994-02-14
Abstract: A teat for feeding liquids to animals has fastening means enabling the teat to be fastened to a source of liquid such as pipe or drum in use to project outwardly from the source. The teat is resilient having an outer end (9) which is closed apart from a slit (11) in it which slit is itself normally adapted to be closed to provide a liquid seal. The closed outer end is preferably concave, coned, cusped or otherwise reentrant. Integral reinforcing means such as webs are located internally on either side of the slit so that if the end of the teat is squashed or compressed by sucking forces exerted by the animal with components along the direction of slit, the reinforcing means causes the slit to be stretched open, thereby allowing liquid to flow out of it in use. The pulling or stretching action allows an acceptable flow rate from a comparatively small slit which is less prone to tear than a large split. Also a wall-stiffening web is provided, preferably as a transverse web (101) integral with the reinforcing means webs, extending from at or near the slit towards the inlet end of the teat, to provide internal stiffening, and acting in conjunction with the resilients to hold the slit closed when no sucking is occuring.
Patent NZ-252429-A (NZ)
Title: Human cytokine oncoinhibin (28 kda) with broad anti-neoplastic activity and compositions thereof
Inventor: AGGARWAL BHARAT B
IPC: C12P21/00
Filed: 1993-04-23
Abstract: The present invention provides a novel human cytokine termed Oncoinhibin. The protein Oncoinhibin is secreted by human erythroblastoid cells, has a molecular weight of approximately 28 kDa and exerts diverse neoplastic activity. The present invention also provides a method for the preparation of human Oncoinhibin.
Patent NZ-257150-A (NZ)
Title: Flanged joint with interposed gasket carrying strain sensors adjacent bolts
Inventor: SPERRING CHRISTOPHER
IPC: G01L23/18
Filed: 1993-10-21
Abstract: PCT No. PCT/GB93/02175 Sec. 371 Date Apr. 20, 1995 Sec. 102(e) Date Apr. 20, 1995 PCT Filed Oct. 21, 1993 PCT Pub. No. WO94/11718 PCT Pub. Date May 26, 1994.A joint which comprises a first joint component having an axial aperture and a second joint component having an axial aperture arranged coaxially with the aperture in the first joint component. The joint components have a gasket ring interposed therebetween to act as a fluid seal. The components are joined by bolts and within the gasket ring are a number of stress or strain responsive elements equispaced around the entire periphery of the gasket ring, each comprising a pair of electrodes sandwiching a stress or strain responsive material. The responsive elements have opposed faces which are spaced from the opposed faces of the gasket ring and the electrodes and are connected to an output via leads to give an indication of the stress or strain within each individual element corresponding to the torque force applied to a proximate bolt.
Patent NZ-299257-A (NZ)
Title: Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
Inventor: FRENZ JOHN HENRY
IPC: A61K38/46
Filed: 1996-08-29
Abstract: The use of deaminated human Dnase in the manufacture of a medicament for the treatment of accumulated purulent material and pulmonary diseases.
Patent NZ-334755-A (NZ)
Title: Boat game which simulates a yacht race
Inventor: STRAUSS WILHELM GEORG FERDINAN
IPC: A63F3/00
Filed: 1999-03-17
Abstract: Disclosed is a game that simulates racing between sailing boats, using a board with a grid, dice and playing  pieces.
Patent NZ-334951-A (NZ)
Title: Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide
Inventor: DENNY WILLIAM ALEXANDER
IPC: A61K31/473
Filed: 1997-10-17
Abstract: A process for the production of the anti-cancer drug N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and derivatives thereof.  The process involves acridine carboxamide of formula I wherein, each of R1, R2, R5 and R6, which may be the same or different, is H, C1 -C6 alkyl, C1 -C6 alkoxy, aryloxy, aralkyloxy, halogen, phenyl, CF3, NO2, NH2, N(R)2, NHCOR, NHCOOR, NHR4, OH, SH, SR or S (R)2; R4 is H, COR, SO2R, COPh, SO2Ph or C1 -C6 alkyl optionally substituted by OH or amino, and R is C1 -C6 alkyl; or R1 and R2, or R5 and R6, together form a methylenedioxy group; X is an integer of 1 to 6; Y is N(R)2 as defined above; or a pharmaceutically acceptable salt thereof. The process comprises: (a) cyclising a compound of formula (II) wherein R1, R2, R5 and R6 are as defined above and R3 is C1 -C6 alkyl, aryl or aryl-C1 -C3 -alkyl, by treatment with boron trifluoride in an organic solvent, to obtain the tetrafluoroborate salt of formula (IIIa): wherein R1, R2, R3, R5 and R6 are as defined above, followed by treatment of the salt with an inorganic base in EtOAc or CH2Cl2 to generate a compound of formula (III) wherein R1, R2, R3, R5 and R6 are as defined above, and (b) treating either (i) the compound of formula (III) as defined above with a primary alkylamine of the formula (IV):     NH2(CH2)xY      wherein X and Y are as defined above, or (ii) the carboxylic acid obtainable by hydrolysing the compound of formula (III) as defined above, under basic conditions, with a primary alkyl amine of formula (IV) as defined above in the presence of a suitable coupling agent, to obtain a compound of formula (I) as defined above; and (c) if desired, converting one compound of formula (I) into another compound of formula (I), and/or converting a compound of formula (I) into a pharmaceutically acceptable salt thereof.
Patent NZ-336718-A (NZ)
Title: Biodegradable targetable microparticle delivery system containing a polymer comprising alpha-hydroxy acids and/or pseudo alpha-amino acids
Inventor: SOKOLL KENNETH K
IPC: A61K9/48
Filed: 1997-12-19
Abstract: A biodegradable, biocompatible polymer has a backbone of the formula (I) wherein: R1, R2, R3, R4 and R5 are independently H or alkyl group; R6 is H, an amine protecting group, a spacer molecule or a biologically active species; X is O or S and x and y are integers. At least about 95% of the polymer can be comprised of a hydroxy acid residues. A particulate carrier for delivery of a biologically active material such as a Haemophilus influenzae protein to a host comprises the polymer backbone as defined above.
Patent NZ-337377-A (NZ)
Title: Determining the stability of a water-hydrocarbon emulsion using thermogravimetry
Inventor: FAURE YAN
IPC: G01N33/28
Filed: 1998-02-26
Abstract: The stability of a water-hydrocarbon emulsion is measured using thermogravimetry.  A crucible 5 is suspended in a container 2 of the emulsion to be studied.  The crucible is attached to a thermogravimetric balance 4.  The temperature of the emulsion is brought of a pre-determined test temperature, and the variation in the apparent weight of the crucible is measured.  The emulsion is then maintained at the predetermined temperature, and again, the variation in the apparent weight of the crucible is measured, and a curve of the variation in weight with time is plotted.  The mass of separated phase, and the speed of separation of the phases is determined from the curve, and compared with reference emulsions having known properties.
Patent NZ-502015-A (NZ)
Title: Ion-exchange process for the purification of nutrients from food process streams
Inventor: SLEIGH ROBERT WALTER
IPC: A23L33/20
Filed: 1998-07-24
Abstract: A separation process for isolation and purification of useful nutrients from food process streams comprises the steps of: a) contacting an aqueous solution including a nutrient and divalent ions with an ion- exchange resin including monovalent ions to deplete the concentration of divalent ions in the solution, b) subjecting the eluate to a process capable of separating monovalent ions (preferably a membrane process such as nanofiltration) to obtain a permeate fraction including monovalent ions and a retentate fraction including the nutrient, c) separating the retentate into fractions, wherein at least one of the fractions includes the major portion of the nutrient, which may then be further purified, d) regenerating the ion-exchange resin by contacting the ion-exchange resin with a solution including the permeate fraction (from step (b)) until a major portion of divalent ions in the ion exchange resin have been replaced by monovalent ions. The aqueous solution may be dairy process streams (such as sweet cheese whey permeate, acid whey permeate, milk permeate or liquor from a lactose crystallisation process), raw beet and cane juice extract, beet and cane molasses, hydrolyzed starch, fruit and vegetable juices, extracts of animal products or extracts of microbial origin.  The nutrient isolated may be carbohydrates, vitamins, peptides, proteins or minerals.
Patent NZ-502258-A (NZ)
Title: Rolling door drive with cam to pivot motor into and out of engagement with drive unit
Inventor: LEIVENZON JACK
IPC: E06B9/74
Filed: 1996-12-20
Abstract: Motor 18 and drive gear 15 are pivoted to engage a gear drive (not shown) so as to drive the rolling door.  This is achieved by camming action of assembly 19 with resilient biasing of gear 15.
Patent NZ-506049-A (NZ)
Title: Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous system
Inventor: PATCHEV VLADIMIR
IPC: A61P5/24
Filed: 1999-02-10
Abstract: The steroids of the formula shown are useful for selectively supplementing estrogen deficiency in the central nervous system without affecting other organs or systems.  The variables are defined as follows: R1 is H, -OH, or alkoxy; R2 is H, alkyl, acyl, or -SO2NR10R11 (where R10 and R11 are independently H or alkyl, or together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino or morpholino ring); R3 is H or -OH; R4 is H, -OH, or alkyl; R5 and R6 are independently H or halogen; R7 is H or methyl; R8 is H, -OH, =O, or a group of formula -CR12R13 (in which R12 and R13 are independently H or halogen); R9 is methyl or ethyl; Z is a C,C double bond or an optionally substituted cyclopropane ring; The >CR5R6 is either in the a or b position, R7 being in the b position if >CR5R6 is in the a position, and vice versa.
Patent NZ-508100-A (NZ)
Title: Optically active (1S)-(-)-2,10-camphorsultam in the preparation of optically active 2S-(2-propenyl)octanoic, 2S-(2-propynyl)octanoic and 2S-(2-propyl)octanoic acids to a high optical purity
Inventor: YAMAMOTO HISASHI
IPC: C07C51/36
Filed: 1999-05-11
Abstract: Optically active octanoic acid derivatives are intermediates useful in the preparation of medicaments.  N-(2S-(2-propenyl)octanoyl)-(1S)-(-2,10-camphorsultam, N-(2S-(2-propynyl)octanoyl)-(1S)-(-)-2,10-camphorsultam and N-(2R-(2-propyl)octanoyl)-(1S)-(-)-2,10-camphorsultam, processes for the preparation of the intermediates and processes for the preparation of optically active 2S-(2-propenyl)octanoic acid, 2S-(2-propynyl)octanoic acid and 2R-propyloctanoic acid are described.  Optically active 2R-propyloctanoic acid is equivalent or superior to that prepared by the process of the prior art in optical purity and can be prepared with fewer reaction steps.
Patent NZ-511811-A (NZ)
Title: Packaging for bottle
Inventor: SIMOTTEL BENOIT
IPC: B65D81/03
Filed: 1999-12-03
Abstract: A package for bottles, comprising an envelope (1) having parts which are alternatively planar (6) and accordion-folded (7), and capable of being unfolded to receive a liquid for refrigerating the bottle (B). Each accordion-folded part (7) is folded on either side of a planar folding line (11), extending in zigzag from the base (5) of the envelope (1) to the free edge (12) thereof.
Patent NZ-513429-A (NZ)
Title: Combinations of a vascular damaging agent and a inhibitor of the formation or action of nitric oxide for the treatment of diseases involving angiogenesis
Inventor: DAVIS PETER DAVID
IPC: A61P17/06
Filed: 2000-02-15
Abstract: Compositions for the inhibition of the formation of new vasculature by angiogenesis are provided comprising the combination of a vascular damaging agent, other than a cytokine releasing anticancer agent, and an inhibitor of the formation or action of nitric oxide in mammalian systems. There are also provided the use of said combinations in medicaments and kits of said compounds and treatment employing said materials. Particularly preferred vascular damaging agents include tubulin-binding agents and antibodies targeted to vasculature, and more preferably include N-acetylcolchinol and N-acetylcolchinol-O- phosphate. Preferred nitric oxide inhibitors include derivatives of arginine, ornithine, lysine, citrulline, S- alkylthioureas or aminoguanidine. Such compositions are useful in the treatment of diseases involving active angiogenesis, such as cancer, especially solid tumors, psoriasis, diabetic retinopathy, macular degeneration, artherosclerosis and rheumatoid arthritis.
Patent NZ-520722-A (NZ)
Title: Stirling engine thermal system improvements
Inventor: KAMEN DEAN L
IPC: F02G1/044
Filed: 2001-03-01
Abstract: A thermal cycle engine (96) having a heat exchanger for transferring thermal energy across the heater head (100) from a heated external fluid to the working fluid. The heat exchanger has a set of heat transfer pins (124) each having an axis directed away from the cylindrical wall of the expansion cylinder (115), or, alternatively, a set of fins substantially aligned with the axis of the expansion cylinder. The height and density of the heat transfer pins (124) may vary with distance in the direction of the flow path, and the pin structure may be fabricated by stacking perforated rings in contact with a heater head. A ring burner supplements the main combustor for supplying additional fuel to cause additional combustion of the exhaust gas. A regenerator (134) for the thermal cycle engine (96) has a random network of fibers formed to fill a specified volume and a material for cross-linking the fibers at points of close contact between fibers of the network.
Patent NZ-521074-A (NZ)
Title: A portable ski tow
Inventor: THOMAS DEAN TE WERA
IPC: B61B11/00
Filed: 2001-02-07
Abstract: A portable ski tow mechanism utilizing a first winch (1) positioned adjacent one end of the ski run. The main ski rope (9) is wound onto a cable drum of the first winch (1). The rope (9) can be partly withdrawn and the free end transported to a remote location. The cable drum is rotated to wind the ski rope (9) onto the cable drum and to pull the skiers up the ski slope. In a modification, a second winch (20) is utilised. The second winch (20) has a cable drum on which an auxiliary rope (21) is wound. The free end of the auxiliary rope (21) is joined (22) to the free end of the main ski rope (9) and the auxiliary rope (21) is wound onto the cable drum of the second winch (20) to withdrawn the main ski rope (9) from the first winch (1). The two winches (1, 20) can be located at the same end of the ski run or at the opposite ends of the ski run.
Patent NZ-526090-A (NZ)
Title: Snow making method and apparatus with water inside hoses that are inflated and deflated
Inventor: BUCCERI ALFIO
IPC: F25C3/04
Filed: 2001-11-05
Abstract: A snow making method and apparatus is disclosed wherein water (3) in flexible hoses (2), within a cooling medium (1) is converted to snow and/or ice crystals. The hoses (2) are cyclically inflated and deflated to cause the crystals to be dislodged from the inner wall surfaces of the hoses (2). When the hoses (2) are full of crystals, the crystals can be discharged by pumping or blowing.
Patent NZ-526846-A (NZ)
Title: Chemical compounds
Inventor: DEATON DAVID N
IPC: C07D333/38
Filed: 2001-12-17
Abstract: Formula I, a beta-3 agonist is disclosed (see below). The use of formula I is described in the manufacture of a medicament for the treatment or prevention in a mammal of diseases susceptible of amelioration by an atypical beta-adrenoceptor agonist. In particular, the use of the compound below is described as useful for the treatment of diabetes or obesity.
Patent NZ-536477-A (NZ)
Title: Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
Inventor: JIAO RICHARD
IPC: A61P29/00
Filed: 2003-04-25
Abstract: Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine compounds of the formula (I) that are suitable for use as modulators of chemokine receptor activity are disclosed, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n and the dashed line are as defined in the specification. These compounds are particularly useful as modulators of the chemokine receptor CCR-2.
Patent NZ-537204-A (NZ)
Title: Oral pharmaceutical forms of liquid drugs having improved bioavailability
Inventor: SANTUS GIANCARLO
IPC: A61K9/20
Filed: 2003-06-20
Abstract: Disclosed is a pharmaceutical composition for oral administration consisting of an admixture absorbed in a solid inert carrier, said admixture comprising: i) one or more liquid active ingredients; ii) one or more surfactants; iii) optionally a co-surfactant; and iv) optionally an absorption enhancer; wherein said composition forms an oil-in-water emulsion upon contact with aqueous media. In particular the liquid active ingredient can be a NO-releasing non-steroidal anti-inflammatory drug, nicotine, nitroglycerin, valproic acid, benzonatate, clofibrate, clorfeniramine, clorfenoxamine, clorfentermina, clorpromazine, liquid vitamins and mixtures thereof.